This graphic shows how the large data set was narrowed down to identify 14 plasma metabolite biomarkers out of the millions of possibilities using a method called bidirectional Mandelian randomization ...
Acute coronary syndrome (ACS) encompasses a spectrum of clinical conditions precipitated by sudden, reduced blood flow to the myocardium. Often resulting from coronary plaque rupture and subsequent ...
Cardiovascular imaging, particularly in the setting of acute myocardial infarction (AMI), has advanced rapidly in recent years, with growing attention to ...
Ankylosing spondylitis (AS) is increasingly recognized as an independent risk factor for premature myocardial infarction (MI), yet the molecular bridge linking chronic axial inflammation to acute ...
Ankylosing spondylitis (AS) is increasingly recognized as an independent risk factor for premature myocardial infarction (MI), yet the molecular bridge linking chronic axial inflammation to acute ...
Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...
Bidirectional Mendelian randomization uncovers link between plasma metabolites and heart attack risk
Myocardial infarction, more commonly known as a heart attack, is a leading cause of death worldwide. Biomarkers called plasma metabolites may play a key role in the physiological pathways involved in ...
Acute ischemic stroke, resulting from the occlusion of cerebral arteries, remains a leading cause of morbidity and mortality worldwide. In recent years, there has been growing recognition that cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results